-
Je něco špatně v tomto záznamu ?
Proteostasis as a Sentry for Sperm Quality and Male Fertility
P. Sutovsky, N. Zelenkova, P. Postlerova, M. Zigo
Jazyk angličtina
Typ dokumentu časopisecké články, přehledy
- MeSH
- fertilita * fyziologie MeSH
- homeostáze proteinů * fyziologie MeSH
- lidé MeSH
- mužská infertilita * metabolismus genetika patologie patofyziologie MeSH
- spermatogeneze * MeSH
- spermie * metabolismus patologie fyziologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
In the last two decades, a school of thought emerged that perceives male reproductive health, testicular function, and sperm output as a sentry for general, somatic health. Large-scale epidemiologic studies have already linked the reduced sperm count to increased risk of chronic somatic disease (e.g., cancer, cardiovascular, neurological and bone diseases), yet most of these studies have not taken full advantage of advanced andrological analysis. Altered proteostasis, i.e., the disbalance between protein synthesis and turnover, is a common denominator of many diseases, including but not limited to cancer and neurodegenerative diseases. This chapter introduces the concept of cellular proteostasis as a measure of sperm structural and functional integrity and an endpoint of varied impacts on spermiogenesis and sperm maturation, including heritability, general health, lifestyle, and occupational and environmental reprotoxic exposure. Special consideration is given to small molecule protein modifiers, sperm-binding seminal plasma proteins, zinc-interacting proteins, and redox proteins responsible for the maintenance of protein structure and the protection of spermatozoa from oxidative damage. While the main focus is on human male infertility, serious consideration is given to relevant animal models, and in particular to male food animals with extensive records of fertility from artificial insemination services. Altogether, the proteostatic biomarker discovery and validation studies set the stage for the integration of proteomics of sperm proteostasis with genomic and high throughput phenomic approaches to benefit both human and animal reproductive medicine.
Department of Obstetrics Gynecology and Women's Health University of Missouri Columbia MO USA
Division of Animal Sciences University of Missouri Columbia MO USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016412
- 003
- CZ-PrNML
- 005
- 20250731092900.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/978-3-031-82990-1_12 $2 doi
- 035 __
- $a (PubMed)40301261
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a x
- 100 1_
- $a Sutovsky, Peter $u Division of Animal Sciences, University of Missouri, Columbia, MO, USA. sutovskyp@missouri.edu $u Department of Obstetrics, Gynecology and Women's Health, University of Missouri, Columbia, MO, USA. sutovskyp@missouri.edu
- 245 10
- $a Proteostasis as a Sentry for Sperm Quality and Male Fertility / $c P. Sutovsky, N. Zelenkova, P. Postlerova, M. Zigo
- 520 9_
- $a In the last two decades, a school of thought emerged that perceives male reproductive health, testicular function, and sperm output as a sentry for general, somatic health. Large-scale epidemiologic studies have already linked the reduced sperm count to increased risk of chronic somatic disease (e.g., cancer, cardiovascular, neurological and bone diseases), yet most of these studies have not taken full advantage of advanced andrological analysis. Altered proteostasis, i.e., the disbalance between protein synthesis and turnover, is a common denominator of many diseases, including but not limited to cancer and neurodegenerative diseases. This chapter introduces the concept of cellular proteostasis as a measure of sperm structural and functional integrity and an endpoint of varied impacts on spermiogenesis and sperm maturation, including heritability, general health, lifestyle, and occupational and environmental reprotoxic exposure. Special consideration is given to small molecule protein modifiers, sperm-binding seminal plasma proteins, zinc-interacting proteins, and redox proteins responsible for the maintenance of protein structure and the protection of spermatozoa from oxidative damage. While the main focus is on human male infertility, serious consideration is given to relevant animal models, and in particular to male food animals with extensive records of fertility from artificial insemination services. Altogether, the proteostatic biomarker discovery and validation studies set the stage for the integration of proteomics of sperm proteostasis with genomic and high throughput phenomic approaches to benefit both human and animal reproductive medicine.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a homeostáze proteinů $x fyziologie $7 D000074702
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a spermie $x metabolismus $x patologie $x fyziologie $7 D013094
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a mužská infertilita $x metabolismus $x genetika $x patologie $x patofyziologie $7 D007248
- 650 12
- $a fertilita $x fyziologie $7 D005298
- 650 12
- $a spermatogeneze $7 D013091
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zelenkova, Natalie $u Division of Animal Sciences, University of Missouri, Columbia, MO, USA $u Department of Veterinary Sciences, Faculty of Agrobiology, Food, and Natural Resources, Czech University of Life Sciences, Prague, Czech Republic
- 700 1_
- $a Postlerova, Pavla $u Department of Veterinary Sciences, Faculty of Agrobiology, Food, and Natural Resources, Czech University of Life Sciences, Prague, Czech Republic $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
- 700 1_
- $a Zigo, Michal $u Division of Animal Sciences, University of Missouri, Columbia, MO, USA
- 773 0_
- $w MED00008501 $t Advances in experimental medicine and biology $x 0065-2598 $g Roč. 1469 (2025), s. 273-303
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40301261 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731092855 $b ABA008
- 999 __
- $a ok $b bmc $g 2366924 $s 1253537
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 1469 $c - $d 273-303 $e - $i 0065-2598 $m Advances in experimental medicine and biology $n Adv Exp Med Biol $x MED00008501
- LZP __
- $a Pubmed-20250708